EU approves ramp-up of Pfizer vaccine manufacturing site in Belgium
By Reuters Staff
1 Min Read
April 23 (Reuters) – The EU medicines regulator on Friday approved an expansion in manufacturing capacity of the Pfizer/BioNtech COVID-19 vaccine in Belgium, while recommending an approval for a new filling line at Moderna’s site in Spain. (Reporting by Yadarisa Shabong in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Bitcoin 
Ethereum 
XRP 
Tether 
Solana 
BNB 
USDC 
Dogecoin 
Cardano 
Lido Staked Ether